- Home
- ATNF vs RELI Comparison
ATNF vs RELI Comparison
Compare ATNF & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- RELI
- Stock Information
- Founded
- ATNF 2016
- RELI 2013
- Country
- ATNF United States
- RELI United States
- Employees
- ATNF N/A
- RELI N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- ATNF Health Care
- RELI Finance
- Exchange
- ATNF Nasdaq
- RELI Nasdaq
- Market Cap
- ATNF 2.6M
- RELI 2.5M
- IPO Year
- ATNF N/A
- RELI N/A
- Fundamental
- Price
- ATNF $2.65
- RELI $2.59
- Analyst Decision
- ATNF
- RELI Strong Buy
- Analyst Count
- ATNF 0
- RELI 1
- Target Price
- ATNF N/A
- RELI $119.00
- AVG Volume (30 Days)
- ATNF 127.9K
- RELI 5.2M
- Earning Date
- ATNF 02-13-2025
- RELI 11-07-2024
- Dividend Yield
- ATNF N/A
- RELI N/A
- EPS Growth
- ATNF N/A
- RELI N/A
- EPS
- ATNF N/A
- RELI N/A
- Revenue
- ATNF N/A
- RELI $14,078,473.00
- Revenue This Year
- ATNF N/A
- RELI N/A
- Revenue Next Year
- ATNF $54.15
- RELI N/A
- P/E Ratio
- ATNF N/A
- RELI N/A
- Revenue Growth
- ATNF N/A
- RELI 4.71
- 52 Week Low
- ATNF $1.16
- RELI $1.18
- 52 Week High
- ATNF $17.75
- RELI $18.53
- Technical
- Relative Strength Index (RSI)
- ATNF 57.11
- RELI 70.08
- Support Level
- ATNF $1.79
- RELI $1.18
- Resistance Level
- ATNF $2.02
- RELI $5.11
- Average True Range (ATR)
- ATNF 0.18
- RELI 0.30
- MACD
- ATNF 0.05
- RELI 0.16
- Stochastic Oscillator
- ATNF 82.47
- RELI 41.42
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.